Peter J. Neumann, ScD

Recent Work

• 

  A Strategy for Value-Based Drug Pricing Under the Inflation Reduction Act

  To make sure that CMS is getting its money’s worth for today’s drugs, it must ensure that the maximum fair price is aligned to drug value.

  By Jason Shafrin, PhD, Darius Lakdawalla, PhD, Jalpa A. Doshi, PhD, Louis P. Garrison, PhD, Anup Malani, PhD, Peter J. Neumann, ScD, Charles E. Phelps, PhD, Adrian Towse, MA, MPhil and Richard J. Willke, PhD

  Categorized in

  • Articles
  • Perspective
• 

  Comments to CMS on the Inflation Reduction Act’s Drug Price Negotiation Program

  Over 20 researchers cosigned a comment letter to Centers for Medicaid and Medicare Services providing recommendations for the Medicare Drug Price Negotiation Program

  By Dana Goldman, PhD, Charles E. Phelps, PhD, Darius Lakdawalla, PhD, Joseph Grogan, JD, Karen Van Nuys, PhD, Barry Liden, JD, William Padula, PhD, Peter J. Neumann, ScD, Louis P. Garrison, PhD and Diana Brixner, PhD, RPh, FAMCP, Beth Devine, PhD, PharmD, MBA, Daniel C. Malone, RPh, PhD, FAMCP, David J. Vanness, PhD, Dan Ollendorf, PhD, James D. Chambers, PhD, MPharm, MSc, Julia F. Slejko, PhD, Manish K. Mishra, MD, MPH, R. Brett McQueen, PhD, Emmanuel F. Drabo, PhD, Joseph F. Levy, PhD, David D. Kim, PhD, Kelly E. Anderson, PhD, Jeromie Ballreich, PhD, MHS, Vasco M. Pontinha, PhD

  Categorized in

  • Articles
  • Perspective
• 

  Addressing Challenges to Alternative Payment Models for New Alzheimer’s Disease Therapies for US Commercial Payers

  Developing a blueprint to overcome challenges in implementing new payment models will ensure better access.

  Categorized in

  • Research
  • Journal Articles
• 

  Improving Care of People with Serious Medical Illness: An Economic Research Agenda for Palliative Care

  In 2020, Schaeffer Center established an Advisory Panel on Palliative Care. In this post, the panel outlines next steps to increase the quality of care of frail people with multiple chronic conditions.

  By Mireille Jacobson, PhD, Peter May, PhD, R. Sean Morrison, MD, Bryan Tysinger, PhD, Jennifer Moore Ballentine, MA, Romilla Batra, MD, Susan Enguidanos, PhD, MPH, Torrie Fields, MPH, Melissa M. Garrido, PhD, David Grabowski, PhD, Haiden Huskamp, PhD, Alexis Coulourides Kogan, PhD, Margaret Maguire, JD, Matthew Modes, MD, Peter J. Neumann, ScD, Holly Prigerson, PhD, Sunita Puri, MD, Bradley Rosen, MD, Thomas J. Smith, MD, Sally Stearns, PhD, Jennifer Temel, MD and Joan Teno, MD

  Categorized in

  • Evidence Base
• 

  Create a U.S. Institute of Health Technology Assessment to Preserve Innovation and Control Costs

  Americans need affordable, accessible and innovative health care. An important first step that can be taken without risking heavy-handed intervention is for Congress to establish an independent Institute of Health Technology Assessment.

  By Darius Lakdawalla, PhD, Peter J. Neumann, ScD and Gail R. Wilensky, PhD

  Categorized in

  • Articles
  • Perspective